ABSTRACT
Hyperamylasemia is a common complication during lamivudine use. We report a case of a pancreatitis following lamivudine therapy. A careful monitoring of amylase levels during treatment with lamivudine is discussed, mainly in the first weeks, considering the cost of this exam and further complication.
Subject(s)
Humans , Male , Middle Aged , Hyperamylasemia/chemically induced , Lamivudine/adverse effects , Pancreatitis/chemically induced , Reverse Transcriptase Inhibitors/adverse effects , Acute Disease , Hepatitis B, Chronic/drug therapy , Lamivudine/therapeutic use , Pancreatitis/enzymology , Reverse Transcriptase Inhibitors/therapeutic useABSTRACT
A invasao desordenada de ecotopos naturais, a falta de controle de vetores biologicos de doencas infecciosas, as mudancas nas interacoes hospedeiro-parasita em condicao de imunodepressao e as alteracoes dos agentes infecciosos sao alguns dos fatores relacionados a emergencia de varias doencas infecto-parasitarias, entre as quais a dengue, a infeccao por hantavirus, a leishmaniose, a tuberculose, a infeccao por Trypanosoma cruzi. A migracao de grandes contingentes populacionais do campo para as metropoles propiciou a endemizacao de algumas doencas tipicamente de ambientes rurais como a...